IP Library Granted Patent US 12,059,369
Granted Patent B2
US 12,059,369 · App. 16/825,964 · Granted Aug 13, 2024

Variable stiffness flexure

Inventors: Thomas C. Kochem (Watertown, MA); Daniel A. Beaudet (Lexington, MA); Stephen Perry (Shirley, MA)
Assignee: Hologic, Inc.
A61F6/144A61F6/142A61F6/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,059,369
App. No.
16/825,964
Granted
Aug 13, 2024
Kind
B2
Abstract

An intrauterine device includes a central support member, first and second internal flexures and first and second external flexures. The first and second internal flexures each include a first section having a first stiffness, a second section having a second stiffness, and third section having a third stiffness, wherein the second stiffness is more flexible than the first and third stiffness and wherein the first section of each internal flexure is coupled to the central support member. The first and second external flexures are coupled to the central support member and coupled to the third sections of the first and second internal flexures, the first and second external flexures in combination with the first and second internal flexures being configured to extend from a collapsed position parallel to the central support member to a deployed position flexing away from the central support member.

Claims (32)

1. An intrauterine ablation device, comprising:

a central support elongate member;

an energy applicator operatively coupled to a distal end portion of the central support elongate member, the energy applicator comprising a tissue contacting member and an expandable-collapsible support structure underlying the tissue contacting member, the expandable-collapsible support structure comprising a first flexure having a first flexure distal tip, and a second flexure having a second flexure distal tip, wherein the expandable-collapsible support structure is adjustable between a collapsed configuration in which the first and second flexure distal tips are closely apposed to one another, and an expanded configuration in which the first and second flexure distal tips are spaced apart from one another; and

a central bridge having a first curved portion and a second curved portion, wherein the first curved portion has a proximal end attached to the first flexure and a distal end attached to a distal end of the second curved portion, the second curved portion having a proximal end attached to the second flexure,

wherein the respective proximal ends of the first and second curved portions are coupled to the central support elongate member; and

wherein each of the first and second curved portions of the central bridge assumes a continuously curved configuration between their respective proximal and distal ends when the expandable-collapsible support structure is in the expanded configuration.

2. The intrauterine ablation device of claim 1 , wherein the central bridge comprises a flexible ribbon or thin flexible membrane.

3. The intrauterine ablation device of claim 1 wherein an outer surface of the central bridge contacts the first flexure and the second flexure.

4. An intrauterine ablation device, comprising:

a central support elongate member configured for transcervical insertion;

an energy applicator operatively coupled to the central support elongate member, the energy applicator comprising a tissue contacting member and an expandable-collapsible support structure underlying the tissue contacting member, the expandable-collapsible support structure comprising a first outer flexure and a second outer flexure, each of the outer flexures having a respective outer surface in lateral contact with an inner surface of the tissue contacting member, and a first inner flexure and a second inner flexure, wherein the expandable-collapsible support structure is adjustable between a collapsed configuration in which the first and second inner flexures are closely apposed to one another, and an expanded configuration in which the first and second inner flexures are spaced apart from one another;

a central bridge having a first curved portion and a second curved portion, wherein the first curved portion has a proximal end attached to a middle portion of the first inner flexure and a distal end coupled to a distal end of the second curved portion, the second curved portion has a proximal end attached to a middle portion of the second inner flexure,

wherein the respective proximal ends of the first and second curved portions are coupled to the central support elongated member; and

wherein the respective distal ends of the first and second curved portions are in contact with the inner surface of the tissue contacting member when the expandable-collapsible support structure is in the expanded configuration.

5. The intrauterine ablation device of claim 4 , wherein the central bridge comprises a flexible ribbon or thin flexible membrane.

6. The intrauterine ablation device of claim 4 , wherein the first curved portion and the second curved portion of the central bridge define respective concave surfaces that face each other when the expandable-collapsible support structure is in the expanded configuration.

7. The intrauterine ablation device of claim 6 , wherein the first curved portion and the second curved portion of the central bridge further define respective convex surfaces in which the convex surface of the first curved portion faces the first inner flexure and the convex surface of the second curved portion faces the second inner flexure when the expandable-collapsible support structure is in the expanded configuration.

8. The intrauterine ablation device of claim 4 , wherein an outer surface of the central bridge contacts the first inner flexure and the second inner flexure.

9. The intrauterine ablation device of claim 4 , wherein the central bridge is configured to maintain the inner surface of the tissue contacting member in a spaced-apart configuration when the expandable-collapsible support structure is in the expanded configuration.

10. An intrauterine ablation device, comprising:

a central support elongate member configured for transcervical insertion;

an energy applicator operatively coupled to the central support elongate member, the energy applicator comprising a tissue contacting member and an expandable-collapsible support structure underlying the tissue contacting member, the expandable-collapsible support structure comprising outer flexures in lateral contact with an inner surface of the tissue contacting member and inner flexures disposed in between the outer flexures; and

a central bridge having a first curved portion and a second curved portion end, wherein the first and second curved portions ends of the central bridge are attached to respective middle portions of the inner flexures, wherein the central bridge is in contact with the inner surface of the tissue contacting member when the expandable-collapsible support structure is in an expanded configuration; and

wherein the respective proximal ends of the first and second curved portions are coupled to the central support elongate member.

11. The intrauterine ablation device of claim 10 , wherein the central bridge comprises a flexible ribbon or thin flexible membrane.

12. The intrauterine ablation device of claim 10 , wherein an outer surface of the central bridge contacts a first inner flexure and a second inner flexure.

13. The intrauterine ablation device of claim 10 , wherein the central bridge is configured to maintain the inner surface of the tissue contacting member in a spaced-apart configuration when the expandable-collapsible support structure is in the expanded configuration.

14. The intrauterine ablation device of claim 10 , wherein the first curved portion and the second curved portion of the central bridge define respective concave surfaces that face each other when the expandable-collapsible support structure is in the expanded configuration.

15. The intrauterine ablation device of claim 10 , wherein the first curved portion and the second curved portion of the central bridge further define respective convex surfaces in which the convex surface of the first curved portion faces a first inner flexure and the convex surface of the second curved portion faces a second inner flexure when the expandable-collapsible support structure is in the expanded configuration.

16. The intrauterine ablation device of claim 1 , wherein the first curved portion and the second curved portion of the central bridge define respective concave surfaces that face each other when the expandable-collapsible support structure is in the expanded configuration.

17. The intrauterine ablation device of claim 1 , wherein the first curved portion and the second curved portion of the central bridge further define respective convex surfaces in which the convex surface of the first curved portion faces the first flexure and the convex surface of the second curved portion faces the second flexure when the expandable-collapsible support structure is in the expanded configuration.

18. The intrauterine ablation device of claim 1 , wherein the central bridge is configured to maintain the tissue contacting member in a spaced-apart configuration when the expandable-collapsible support structure is in the expanded configuration.

Assignments (3)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 054089/0804 Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED; FAXITRON BIOPTICS, LLC; GEN-PROBE PRODESSE, INC.
Reel/Frame 075504/0575 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Oct 15, 2020
From: HOLOGIC, INC.; FAXITRON BIOPTICS, LLC; FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 054089/0804 →